阿摩線上測驗
15.使用ipratropium inhalation，下列那一種不良反應發生率最低？
(A)便秘
(B)口乾
(C)上呼吸道感染
(D)味覺異常
統計： A(1356), B(41), C(1175), D(566), E(0) #2972369
詳解 (共 4 筆)
抗膽鹼藥物的藥品吸收性差，吸入劑型較不會引起全身性副作用。
->口乾、味覺異常、呼吸道感染都是局部的
The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.
(C) >10%: Respiratory: Bronchitis (10% to 23%), exacerbation of chronic obstructive pulmonary disease (8% to 23%), sinusitis (1% to 11%)
1% to 10%:
Central nervous system: Headache (6% to 7%), dizziness (3%)
Gastrointestinal: Dyspepsia (1% to 5%), nausea (4%), (B) xerostomia (2% to 4%), (D)dysgeusia (1%)
Genitourinary: Urinary tract infection (2% to 10%)
Neuromuscular & skeletal: Back pain (2% to 7%)
Respiratory: Dyspnea (7% to 8%), flu-like symptoms (4% to 8%), cough (>3%), rhinitis (>3%), upper respiratory tract infection (>3%)
(A) <1%, postmarketing, and/or case reports: Accommodation disturbance, acute eye pain, anaphylaxis, angioedema, blurred vision, bronchospasm, conjunctival hyperemia, constipation, corneal edema, decreased gastrointestinal motility, diarrhea, dry throat, glaucoma, hypersensitivity reaction, hypotension, increased intraocular pressure, laryngospasm, mouth edema, mydriasis, nausea, palpitations, pharyngeal edema, pruritus, skin rash, stomatitis, tachycardia, throat irritation, urinary retention, urticaria, visual halos around lights, vomiting
